A membrane oxygenator is an equipment used to add oxygen (O2) and remove carbon dioxide (CO2) from the blood. It consists of a thin gas absorptive membrane that separates the blood and gas flow in the cardiopulmonary bypass (CPB) circuit. It diffuses the oxygen from the gas side into the blood, and also diffuses carbon dioxide from the blood into the gas. It is used in two principal modes: to oxygenate blood in longer-term life support, and to imitate the function of the lungs in CPB. It is tested on international standards and optimized for various functions like heat transfer efficiency, oxygen transfer, blood flow rate, and carbon dioxide transfer. The best perfusion results are accomplished through a unique Ω flow path.
According to the study, “Global Membrane Oxygenator Market 2019 by Manufacturers, Regions, Type, and Application, Forecast to 2024” the key companies operating in the global membrane oxygenator market areMedos, Kewei (Microport), Sorin, Xijian Medical, Abbott Diabetes Care, Inc., WEGO, Baxter International, Inc., Nipro Corporation, Xenios AG, Asahi Kasei Medical Co., Ltd., HeartWare International, Inc., Vital Therapies, Inc., Fresenius Medical Care AG & Co. KGaA, SynCardia Systems, Inc., Nikkiso Co., Ltd., Medtronic, Inc., Terumo Heart, Inc., Toray Medical Co., Ltd., Thoratec Corp. The key players in the market are pursuing the strategies of approvals, agreements & partnerships, product launches, expansions, and other strategies (rebranding, website launch, product development, acquisition, and market deployment).
Based on type, the membrane oxygenator market is segmented into extracorporeal membrane oxygenation (ECMO) and intravenous membrane oxygenator. Based on product type, the market is segmented into a hollow fiber membrane oxygenator and flat sheet membrane oxygenator. Based on the component, the market is segmented into pumps, cannula, oxygenators, controllers, and accessories. Based on modality, the market is segmented into Venoarterial(VA), Venovenous(VV) and Arteriovenous (AV). VV segment holds the major share in the market owing to the rise in lung transplants, high incidence of respiratory failure, growth in technological advancements and an increase in the incidence of COPD. Based on the patient group, the market is segmented into pediatrics, adults, and neonates. Based on the application, the market is segmented into respiratory, cardiac application and cardiopulmonary resuscitation. The respiratory segment is anticipated to exhibit a higher growth rate due to a rise in the incidence of respiratory failure, lung cancer, and lung transplants, an increase in the adoption of ECMO in hospitals and growth in ECMO centers. In addition, based on end-users, the market is segmented into hospitals, ambulatory centers, home care settings, and others.
The membrane oxygenator market is driven by an increase in prevalence of cardiovascular & respiratory diseases, followed by technological advancements in ECMO machine, growth in adoption of ECMO in lung transplantation procedures, rise in geriatric population & increase in a number of people suffering from diseases and growth in the number of ECMO centers. However, the high cost of ECMO procedures and complications associated with ECMOmay impact the market. Moreover, the rise in survival rates with ECMOis akey opportunity for the market.
Based on geography, the North-American region dominates the membrane oxygenator market owing to growth in cardiovascular & respiratory diseases in the region. Whereas, the European and Asian-Pacific regions are expected to witness higher CAGR due to the rise in adoption of ECMO as a bridge to lung transplantation, and growth in technological advancements over the forecast period. In near future, it is predicted that the market will be reached at a rapid pace on account of rising in conferences & training programs to increase awareness among consumers during the forecast period.
To Know More, Click On The Link Below:-
Ankur Gupta, Head Marketing & Communications